hydroxyproline has been researched along with Hyperparathyroidism in 146 studies
Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.
Hyperparathyroidism: A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
Excerpt | Relevance | Reference |
---|---|---|
"We investigated the effect of alendronate on calcium, PTH, and bone mineral density in 27 female and 5 male patients with primary hyperparathyroidism." | 7.71 | Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: a 2-year study. ( Blackwell, PJ; Fairbairn, KJ; Hosking, DJ; Parker, CR, 2002) |
") infusion of 5 mg alendronate was studied in ten patients with Paget's disease, six patients with primary hyperparathyroidism and ten osteopenic postmenopausal women." | 7.69 | Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone. ( Adami, S; Bertoldo, F; Braga, B; Dorizzi, R; Gatti, D; Locascio, V; Mian, M; Rossini, M; Zamberlan, N, 1994) |
"Galactosylhydroxylysine appears to be a sensitive index of bone resorption, useful in the clinical assessment of bone involvement and in the management of patients with mild primary hyperparathyroidism." | 7.69 | Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism. ( Bertoldo, F; Bettica, P; Braga, V; LoCascio, V; Moro, L; Pasini, AF; Stefani, L, 1994) |
"The aim of this study was to evaluate the effects of ipriflavone treatment on bone remodeling in primary hyperparathyroidism." | 7.68 | Effects of ipriflavone on bone remodeling in primary hyperparathyroidism. ( Carnevale, V; Mazzuoli, G; Minisola, S; Pacitti, MT; Romagnoli, E; Rosso, R; Scarda, A; Scarnecchia, L, 1992) |
" Eleven patients suffering from primary hyperparathyroidism were studied by measuring urinary excretion of hydroxyproline (OHPr) and cAMP in samples collected before PTx and, on the day of surgery, at intervals of 1-3 h for the first 10 h and then at longer intervals." | 7.67 | Acute effects of removal of parathyroid adenoma on plasma and urinary hydroxyproline levels. ( Aliberti, G; Antonelli, R; D'Erasmo, E; Mazzuoli, GF; Medori, C; Minisola, S; Scarda, A; Scarpiello, A; Tabolli, S; Valtorta, C, 1984) |
"Fasting urinary hydroxyproline: creatinine ratio (OHPr:Cr) and bone mineral content of the forearm (BMC) were measured in 125 normals, 67 females and 58 males, aged 20-79 years, and in 15 patients with primary hyperparathyroidism." | 7.67 | Bone mass as referent for urinary hydroxyproline excretion: age and sex-related changes in 125 normals and in primary hyperparathyroidism. ( Hyldstrup, L; Jensen, GF; McNair, P; Nielsen, HR; Transbøl, I, 1984) |
"In eight patients with primary hyperparathyroidism (HPT) the laboratory effects of cyclofenil, which is a synthetic stilbestrol derivative with weak feminizing effects, were studied over a period of 5-13 weeks." | 7.67 | Treatment of primary hyperparathyroidism with cyclofenil--a synthetic stilbestrol derivative with minimal feminizing effects. ( Herbai, G; Ljunghall, S, 1984) |
" To explore a possible relationship between parathormone action on bone and estrogens we studied the activity of the bone isoenzyme of serum alkaline phosphatase and the urinary excretion of hydroxyproline in 16 premenopausal and 24 postmenopausal women with primary hyperparathyroidism with hyperparathyroid osteodystrophy." | 7.67 | The activity of the bone isoenzyme of serum alkaline phosphatase and urinary hydroxyproline excretion in premenopausal and postmenopausal women with primary hyperparathyroidism. ( Broulik, PD; Pacovský, V; Stĕpán, J, 1984) |
"The values of urinary hydroxyproline excretion reflecting the bone remodelling by osteoclasts, and the bone isoenzyme of serum alkaline phosphatase reflecting the osteoblastic function, in 100 randomly selected healthy subjects, 100 patients with primary hyperparathyroidism, and 100 patients with osteolytic secondary tumorous deposits in the skeleton showed a bivariate lognormal distribution." | 7.67 | Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism. ( Bek, V; Broulík, P; Mikulecký, M; Pacovský, V; Stĕpán, JJ, 1989) |
"Osteocalcin (serum bone-Gla protein, sBGP), serum alkaline phosphatase (sAP) and urinary hydroxyproline/creatinine ratio (uOH-Prol/creatinine) have been measured in 21 patients with primary hyperparathyroidism (PHPT) and in nine patients with hypercalcaemia of malignancy (HM)." | 7.67 | Osteocalcin and urinary hydroxyproline/creatinine ratio in the differential diagnosis of primary hyperparathyroidism and hypercalcaemia of malignancy. ( de la Piedra, C; Rapado, A; Toural, V, 1987) |
"The effects of norethindrone (5 mg daily) on biochemical variables and forearm mineral density were assessed in 20 postmenopausal women with mild primary hyperparathyroidism." | 7.67 | Treatment of postmenopausal hyperparathyroidism with norethindrone. Effects on biochemistry and forearm mineral density. ( Horowitz, M; Morris, H; Need, AG; Nordin, BE; Philcox, J; Wishart, J, 1987) |
"A significant correlation between the activity of the bone isoenzyme or serum alkaline phosphatase and the urinary hydroxyproline excretion in osteomalacia, osteoporosis, primary hyperparathyroidism with osteodystrophy, Paget's disease, secondary bone tumours, and in a control group was found (P less than 0." | 7.66 | Relationship of the activity of the bone isoenzyme of serum alkaline phosphatase to urinary hydroxyproline excretion in metabolic and neoplastic bone diseases. ( Formánková, J; Horn, V; Hrba, J; Konopásek, B; Marek, J; Pacovský, V; Silinková-Málková, E; Stĕpán, J; Vokrouhlická, O, 1978) |
"The amounts of total hydroxyproline (THP), free hydroxyproline (FHP) and non-dialysable hydroxyproline (NDHP) excreted in the urine by six patients with chronic renal failure who received kidney transplants and six patients with primary hyperparathyroidism were studied." | 7.65 | Hydroxyproline excretion following renal transplantation: comparison with values found in primary hyperparathyroidism. ( Dixon, SR; Goulding, A; McChesney, R, 1977) |
"Treatment with ethinyl estradiol or norethindrone reduces the bone-turnover rate and plasma calcium levels in normal postmenopausal women, without affecting the secretion of calcium-regulating hormones." | 5.27 | Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women. ( Peacock, M; Selby, PL, 1986) |
"Hydroxyproline was determined under conditions of a very low proline diet and 1." | 5.26 | Urinary hydroxyproline concentration in primary hyperparathyroidism with and without renal stones. ( Sommer-Tsilenis, E, 1977) |
"We investigated the effect of alendronate on calcium, PTH, and bone mineral density in 27 female and 5 male patients with primary hyperparathyroidism." | 3.71 | Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: a 2-year study. ( Blackwell, PJ; Fairbairn, KJ; Hosking, DJ; Parker, CR, 2002) |
") infusion of 5 mg alendronate was studied in ten patients with Paget's disease, six patients with primary hyperparathyroidism and ten osteopenic postmenopausal women." | 3.69 | Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone. ( Adami, S; Bertoldo, F; Braga, B; Dorizzi, R; Gatti, D; Locascio, V; Mian, M; Rossini, M; Zamberlan, N, 1994) |
"Galactosylhydroxylysine appears to be a sensitive index of bone resorption, useful in the clinical assessment of bone involvement and in the management of patients with mild primary hyperparathyroidism." | 3.69 | Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism. ( Bertoldo, F; Bettica, P; Braga, V; LoCascio, V; Moro, L; Pasini, AF; Stefani, L, 1994) |
"The aim of this study was to evaluate the effects of ipriflavone treatment on bone remodeling in primary hyperparathyroidism." | 3.68 | Effects of ipriflavone on bone remodeling in primary hyperparathyroidism. ( Carnevale, V; Mazzuoli, G; Minisola, S; Pacitti, MT; Romagnoli, E; Rosso, R; Scarda, A; Scarnecchia, L, 1992) |
" Eleven patients suffering from primary hyperparathyroidism were studied by measuring urinary excretion of hydroxyproline (OHPr) and cAMP in samples collected before PTx and, on the day of surgery, at intervals of 1-3 h for the first 10 h and then at longer intervals." | 3.67 | Acute effects of removal of parathyroid adenoma on plasma and urinary hydroxyproline levels. ( Aliberti, G; Antonelli, R; D'Erasmo, E; Mazzuoli, GF; Medori, C; Minisola, S; Scarda, A; Scarpiello, A; Tabolli, S; Valtorta, C, 1984) |
"This study was performed in order to evaluate the clinical usefulness of the measurement of total serum alkaline phosphatase activity (AP), serum osteocalcin (BGP) and urinary hydroxyproline (OHPr) in assessing bone remodelling in primary hyperparathyroidism." | 3.67 | Clinical value of the measurement of bone remodelling markers in primary hyperparathyroidism. ( Bigi, F; Carnevale, V; Mazzuoli, GF; Minisola, S; Pacitti, MT; Romagnoli, E; Rosso, R; Scarnecchia, L, 1989) |
"The values of urinary hydroxyproline excretion reflecting the bone remodelling by osteoclasts, and the bone isoenzyme of serum alkaline phosphatase reflecting the osteoblastic function, in 100 randomly selected healthy subjects, 100 patients with primary hyperparathyroidism, and 100 patients with osteolytic secondary tumorous deposits in the skeleton showed a bivariate lognormal distribution." | 3.67 | Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism. ( Bek, V; Broulík, P; Mikulecký, M; Pacovský, V; Stĕpán, JJ, 1989) |
"Fasting urinary hydroxyproline: creatinine ratio (OHPr:Cr) and bone mineral content of the forearm (BMC) were measured in 125 normals, 67 females and 58 males, aged 20-79 years, and in 15 patients with primary hyperparathyroidism." | 3.67 | Bone mass as referent for urinary hydroxyproline excretion: age and sex-related changes in 125 normals and in primary hyperparathyroidism. ( Hyldstrup, L; Jensen, GF; McNair, P; Nielsen, HR; Transbøl, I, 1984) |
"We have measured classic markers of bone turnover, serum alkaline phosphatase (sAP), urinary hydroxyproline/creatinine ratio (uOH-Prol/creatinine) and osteocalcin (sBGP), in two bone disorders characterized by an increase in bone remodelling, namely Paget's disease of bone and primary hyperparathyroidism (PHPT) and in two other bone diseases characterized by an increase in bone resorption without the concomitant increase in bone formation, hypercalcaemia of malignancy (HM) and involutional osteoporosis (IO)." | 3.67 | Osteocalcin and bone remodelling in Paget's disease of bone, primary hyperparathyroidism, hypercalcaemia of malignancy and involutional osteoporosis. ( de la Piedra, C; Rapado, A; Torres, R, 1989) |
"Osteocalcin (serum bone-Gla protein, sBGP), serum alkaline phosphatase (sAP) and urinary hydroxyproline/creatinine ratio (uOH-Prol/creatinine) have been measured in 21 patients with primary hyperparathyroidism (PHPT) and in nine patients with hypercalcaemia of malignancy (HM)." | 3.67 | Osteocalcin and urinary hydroxyproline/creatinine ratio in the differential diagnosis of primary hyperparathyroidism and hypercalcaemia of malignancy. ( de la Piedra, C; Rapado, A; Toural, V, 1987) |
"In eight patients with primary hyperparathyroidism (HPT) the laboratory effects of cyclofenil, which is a synthetic stilbestrol derivative with weak feminizing effects, were studied over a period of 5-13 weeks." | 3.67 | Treatment of primary hyperparathyroidism with cyclofenil--a synthetic stilbestrol derivative with minimal feminizing effects. ( Herbai, G; Ljunghall, S, 1984) |
" To explore a possible relationship between parathormone action on bone and estrogens we studied the activity of the bone isoenzyme of serum alkaline phosphatase and the urinary excretion of hydroxyproline in 16 premenopausal and 24 postmenopausal women with primary hyperparathyroidism with hyperparathyroid osteodystrophy." | 3.67 | The activity of the bone isoenzyme of serum alkaline phosphatase and urinary hydroxyproline excretion in premenopausal and postmenopausal women with primary hyperparathyroidism. ( Broulik, PD; Pacovský, V; Stĕpán, J, 1984) |
"The effects of norethindrone (5 mg daily) on biochemical variables and forearm mineral density were assessed in 20 postmenopausal women with mild primary hyperparathyroidism." | 3.67 | Treatment of postmenopausal hyperparathyroidism with norethindrone. Effects on biochemistry and forearm mineral density. ( Horowitz, M; Morris, H; Need, AG; Nordin, BE; Philcox, J; Wishart, J, 1987) |
"Free hydroxyproline was measured in plasma of 67 normal subjects and in 70 patients with bone disease including primary hyperparathyroidism (n = 19), osteoporosis (n = 18), Paget's disease (n = 14), cancer involving bone (n = 8), chronic renal failure (n = 6), and osteomalacia (n = 6), and osteomalacia (n = 5)." | 3.67 | Clinical significance of free plasma hydroxyproline measurement in metabolic bone disease. ( Antonelli, R; Mazzuoli, G; Minisola, S, 1985) |
"Calcitonin (CT) plasma levels and urinary hydroxyproline (OHPr) excretion were studied in twenty-eight patients (eleven males and seventeen females) with primary hyperparathyroidism in order to ascertain the effect of CT secretion on the severity of bone disease." | 3.66 | Calcitonin secretion and bone disease severity in hypercalcaemic hyperparathyroidism. ( Alberti, LM; D'Erasmo, E; Mancini, D; Mazzuoli, GF; Minisola, S; Scarda, A; Valtorta, C, 1981) |
"A significant correlation between the activity of the bone isoenzyme or serum alkaline phosphatase and the urinary hydroxyproline excretion in osteomalacia, osteoporosis, primary hyperparathyroidism with osteodystrophy, Paget's disease, secondary bone tumours, and in a control group was found (P less than 0." | 3.66 | Relationship of the activity of the bone isoenzyme of serum alkaline phosphatase to urinary hydroxyproline excretion in metabolic and neoplastic bone diseases. ( Formánková, J; Horn, V; Hrba, J; Konopásek, B; Marek, J; Pacovský, V; Silinková-Málková, E; Stĕpán, J; Vokrouhlická, O, 1978) |
"The amounts of total hydroxyproline (THP), free hydroxyproline (FHP) and non-dialysable hydroxyproline (NDHP) excreted in the urine by six patients with chronic renal failure who received kidney transplants and six patients with primary hyperparathyroidism were studied." | 3.65 | Hydroxyproline excretion following renal transplantation: comparison with values found in primary hyperparathyroidism. ( Dixon, SR; Goulding, A; McChesney, R, 1977) |
"Amongst the bone resorption markers studied are: 1) Calcium/creatinine urinary quotient; 2) Tartrate resistant acid phosphatase; 3) Urinary hydroxyproline; 4) Other substance derived from collagen disruption such as hydroxylysine glycoside, piridinolinic intermolecular bridges and the enzymatic activity of proline iminopeptidase." | 2.38 | [Usefulness of bone remodelling biochemical markers in the diagnosis and follow-up of Paget's bone disease, primary hyperparathyroidism, tumor hypercalcemia, and postmenopausal osteoporosis. II. Bone resorption markers]. ( de la Piedra Gordo, C; Torres Jiménez, R, 1990) |
"We related the weight of the parathyroid adenoma to biochemical variables of bone turnover in 53 patients submitted to parathyroidectomy for primary hyperparathyroidism." | 1.27 | Correlation between mass of parathyroid adenoma and biochemical indicators of bone turnover in patients with primary hyperparathyroidism. ( Broulík, PD; Hradec, E; Marek, J; Pacovský, V; Stĕpán, JJ, 1986) |
"Treatment with ethinyl estradiol or norethindrone reduces the bone-turnover rate and plasma calcium levels in normal postmenopausal women, without affecting the secretion of calcium-regulating hormones." | 1.27 | Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women. ( Peacock, M; Selby, PL, 1986) |
"Hydroxyproline was determined under conditions of a very low proline diet and 1." | 1.26 | Urinary hydroxyproline concentration in primary hyperparathyroidism with and without renal stones. ( Sommer-Tsilenis, E, 1977) |
"2." | 1.26 | The relation between bone loss and calcium balance in women. ( Crilly, RG; Horsman, A; Marshall, DH; Nordin, BE; Simpson, M, 1980) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 128 (87.67) | 18.7374 |
1990's | 17 (11.64) | 18.2507 |
2000's | 1 (0.68) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Parker, CR | 1 |
Blackwell, PJ | 1 |
Fairbairn, KJ | 1 |
Hosking, DJ | 2 |
HILLMAN, DA | 1 |
SCRIVER, CR | 1 |
PEDVIS, S | 1 |
SHRAGOVITCH, I | 1 |
BENOIT, FL | 1 |
THEIL, GB | 1 |
WATTEN, RH | 1 |
SMILEY, JD | 1 |
ZIFF, M | 1 |
KLEIN, L | 3 |
LAFFERTY, FW | 1 |
PEARSON, OH | 2 |
CURTISS, PH | 1 |
LEE, CA | 2 |
LLOYD, HM | 2 |
JOHNSTON, CC | 1 |
DEISS, WP | 1 |
AVIOLI, LV | 3 |
MCDONALD, JE | 1 |
SINGER, RA | 1 |
Takahashi, Y | 1 |
Matsuo, M | 1 |
Inoue, H | 1 |
Borel, JP | 1 |
Caranjot, JM | 1 |
Jayle, MF | 1 |
Dubovský, J | 3 |
Hrba, J | 2 |
Pacovský, V | 9 |
Smith, R | 5 |
Minisola, S | 11 |
Medori, C | 1 |
Antonelli, R | 3 |
Scarpiello, A | 1 |
Valtorta, C | 4 |
Tabolli, S | 3 |
Scarda, A | 6 |
Aliberti, G | 2 |
D'Erasmo, E | 3 |
Mazzuoli, GF | 4 |
Douglas, DL | 1 |
Duckworth, T | 1 |
Russell, RG | 2 |
Kanis, JA | 2 |
Preston, CJ | 1 |
Preston, FE | 1 |
Prenton, MA | 1 |
Woodhead, JS | 1 |
Kalinin, AP | 1 |
Fekson, EG | 2 |
Shane, E | 1 |
Baquiran, DC | 1 |
Bilezikian, JP | 1 |
Marcus, R | 1 |
Madvig, P | 1 |
Crim, M | 1 |
Pont, A | 1 |
Kosek, J | 1 |
Hyldstrup, L | 1 |
McNair, P | 1 |
Jensen, GF | 1 |
Nielsen, HR | 1 |
Transbøl, I | 1 |
Herbai, G | 1 |
Ljunghall, S | 2 |
Broulik, PD | 3 |
Stĕpán, J | 2 |
Kruse, K | 1 |
Kracht, U | 1 |
Yumita, S | 1 |
Mancini, D | 1 |
Alberti, LM | 1 |
Graham, JJ | 1 |
Harding, PE | 1 |
Hoare, LL | 1 |
Thomas, DW | 1 |
Wise, PH | 1 |
Horsman, A | 1 |
Marshall, DH | 1 |
Nordin, BE | 5 |
Crilly, RG | 1 |
Simpson, M | 1 |
Brahm, H | 1 |
Ljunggren, O | 1 |
Larsson, K | 1 |
Lindh, E | 1 |
LoCascio, V | 2 |
Braga, V | 1 |
Bertoldo, F | 2 |
Bettica, P | 1 |
Pasini, AF | 1 |
Stefani, L | 1 |
Moro, L | 1 |
Adami, S | 1 |
Zamberlan, N | 1 |
Mian, M | 1 |
Dorizzi, R | 1 |
Rossini, M | 1 |
Braga, B | 1 |
Gatti, D | 1 |
Horowitz, M | 2 |
Wishart, JM | 1 |
Need, AG | 2 |
Morris, HA | 1 |
Romagnoli, E | 6 |
Scarnecchia, L | 6 |
Rosso, R | 6 |
Pacitti, MT | 6 |
Mazzuoli, G | 6 |
Reasner, CA | 1 |
Stone, MD | 1 |
Ballah, A | 1 |
Mundy, GR | 1 |
Carnevale, V | 4 |
Minisola, G | 1 |
Ooms, ME | 1 |
Lips, P | 1 |
Roos, JC | 1 |
van der Vijgh, WJ | 1 |
Popp-Snijders, C | 1 |
Bezemer, PD | 1 |
Bouter, LM | 1 |
Brazier, M | 1 |
Kamel, S | 1 |
Maamer, M | 1 |
Agbomson, F | 1 |
Elesper, I | 1 |
Garabedian, M | 1 |
Desmet, G | 1 |
Sebert, JL | 1 |
Pellegrino, C | 1 |
Ombricolo, E | 1 |
Pisani, D | 1 |
Damiani, C | 1 |
Mazzuoli, SF | 1 |
Haddock, L | 1 |
Aguiló, F | 1 |
Vázquez Quintana, E | 1 |
Vázquez, MC | 1 |
Rabell, V | 1 |
Allende, M | 1 |
Horn, V | 1 |
Silinková-Málková, E | 1 |
Vokrouhlická, O | 1 |
Konopásek, B | 1 |
Formánková, J | 1 |
Marek, J | 2 |
Rosenthall, L | 2 |
Kaye, M | 3 |
Schweigart, U | 1 |
Henderkott, U | 1 |
Paterek, K | 1 |
Hartung, R | 1 |
Zilker, T | 1 |
Bottermann, P | 2 |
Sann, L | 1 |
David, L | 1 |
Thomas, A | 1 |
Frederich, A | 1 |
Chapuy, MC | 2 |
François, R | 1 |
Wiegmann, T | 1 |
Kirsh, J | 1 |
Kaplan, RA | 1 |
Geho, WB | 1 |
Poindexter, C | 1 |
Haussler, M | 1 |
Dietz, GW | 1 |
Pak, CY | 3 |
Kistler, H | 1 |
Halse, J | 1 |
Gordeladze, JO | 1 |
Goulding, A | 1 |
McChesney, R | 1 |
Dixon, SR | 1 |
Enderle, A | 1 |
von Gumppenberg, S | 1 |
Tougaard, L | 1 |
Hau, C | 1 |
Rodbro, P | 1 |
Ditzel, J | 1 |
Leicht, E | 1 |
Langer, HJ | 1 |
Stelzer, K | 1 |
Blum, C | 1 |
Laitinen, O | 3 |
Retallack, RW | 1 |
Jeffries, M | 1 |
Kent, GN | 1 |
Hitchcock, NE | 1 |
Gutteridge, DH | 1 |
Smith, M | 1 |
Sommer-Tsilenis, E | 1 |
Castro, JH | 1 |
Genuth, SM | 1 |
Hecht, A | 1 |
Gershberg, H | 1 |
St Paul, H | 1 |
Roques, CF | 1 |
Mazières, B | 1 |
Amigues, H | 1 |
Fournie, A | 1 |
Arlet, J | 1 |
Ruffié, R | 1 |
Krakauer, JC | 1 |
Kleerekoper, M | 1 |
Mysiak, W | 1 |
Stasiak, L | 1 |
Robins, SP | 1 |
Black, D | 1 |
Paterson, CR | 1 |
Reid, DM | 1 |
Duncan, A | 1 |
Seibel, MJ | 1 |
de la Piedra Gordo, C | 1 |
Torres Jiménez, R | 1 |
Tishenina, RS | 1 |
Podobedova, LI | 1 |
Bigi, F | 3 |
Igarashi, S | 1 |
Stĕpán, JJ | 4 |
Mikulecký, M | 1 |
Bek, V | 1 |
Broulík, P | 2 |
Torres, R | 1 |
de la Piedra, C | 2 |
Rapado, A | 2 |
Hamdy, NA | 1 |
Gray, RE | 1 |
McCloskey, E | 1 |
Galloway, J | 1 |
Rattenbury, JM | 1 |
Brown, CB | 1 |
Presl, J | 1 |
Toural, V | 1 |
Hradec, E | 1 |
Selby, PL | 1 |
Peacock, M | 2 |
Wishart, J | 1 |
Morris, H | 1 |
Philcox, J | 1 |
Charhon, SA | 1 |
Delvin, EE | 1 |
Meunier, PJ | 1 |
Charles, P | 1 |
Poser, JW | 1 |
Mosekilde, L | 1 |
Jensen, FT | 1 |
Gallagher, JC | 2 |
Oberländer, J | 1 |
Hirthe, D | 2 |
Mühlbach, R | 3 |
de Moor, P | 1 |
Bouillon, R | 1 |
Hodgkinson, A | 1 |
Krane, SM | 1 |
Muñoz, AJ | 1 |
Harris, ED | 1 |
Monsaingeon, A | 1 |
Thomas, J | 1 |
Thomas, E | 1 |
Balan, L | 1 |
Adjiman, M | 1 |
Steg, A | 1 |
Aboulker, P | 1 |
Rasmussen, H | 1 |
Goldsmith, RS | 2 |
Bartter, FC | 3 |
Maddison, PJ | 1 |
Bacon, PA | 1 |
Morii, H | 1 |
Drozdz, M | 1 |
Kucharz, E | 1 |
Scuro, LA | 1 |
Lo Cascio, V | 1 |
Dorfmann, H | 1 |
Bordier, P | 3 |
Figueroa, M | 1 |
de Sèze, S | 1 |
Wilkinson, R | 1 |
Ganea, E | 1 |
Lutwak, L | 1 |
Singer, FR | 1 |
Urist, MR | 1 |
Faas, FH | 1 |
Wadkins, CL | 1 |
Daniels, JS | 1 |
Davis, GR | 1 |
Carter, WJ | 1 |
Wynn, JO | 1 |
Seta, K | 1 |
Abe, M | 1 |
Yoshikawa, H | 1 |
Muldowney, FP | 1 |
Donohoe, J | 1 |
Ryan, C | 1 |
Kleeman, CR | 1 |
Massry, SG | 1 |
Coburn, JW | 1 |
Cohen, RD | 1 |
Ney, RL | 1 |
Gill, JR | 1 |
Keiser, HR | 1 |
Haddad, JG | 1 |
Couranz, S | 1 |
East, D | 1 |
Sanzenbacher, L | 2 |
Ruskin, B | 1 |
Cox, J | 1 |
Courvoisier, B | 1 |
Zender, R | 1 |
Siddiqui, AA | 1 |
Wilson, DR | 1 |
Draper, HH | 1 |
Sie, TL | 1 |
Bergan, JG | 1 |
Henneman, DH | 1 |
Lifschitz, MD | 1 |
Riggs, BL | 1 |
Arnaud, CD | 1 |
Taylor, WF | 1 |
McCall, JT | 1 |
Sessler, AD | 1 |
Vaisrub, S | 1 |
Byers, PD | 1 |
Kocher, P | 1 |
Nichols, G | 2 |
Flanagan, B | 2 |
Veer, Jv | 1 |
Kivirikko, KI | 2 |
Cahill, R | 1 |
Westall, RG | 1 |
Hubay, CA | 1 |
Gonzalez-Barcena, D | 1 |
Frankel, V | 1 |
Eckel, RE | 1 |
Cochran, M | 1 |
Sachs, G | 1 |
Trzenschik, K | 1 |
Chikazawa, H | 1 |
Dick, M | 1 |
Kalima, T | 1 |
Uitto, J | 1 |
Kerkhoff, JF | 1 |
Skovsted, L | 1 |
Kristensen, M | 1 |
Siersbaek-Nielsen, K | 1 |
Hansen, JM | 1 |
Fischer, JA | 2 |
Binswanger, U | 2 |
Schenk, R | 2 |
Merz, W | 2 |
Kistler, HJ | 2 |
Franz, HE | 2 |
Ritz, E | 2 |
Kuhn, HM | 1 |
Jahns, E | 1 |
Schenck, P | 1 |
Hartmann, F | 1 |
Corbeel, L | 1 |
Casaer, P | 1 |
Malvaux, P | 1 |
Lormans, J | 1 |
Bourgeois, N | 1 |
Miravet, L | 2 |
Matrajt, H | 1 |
Tun, S | 1 |
Gruson, M | 1 |
Hioco, D | 2 |
Resnick, H | 1 |
Lapp, NL | 1 |
Morgan, WK | 1 |
Dubovská, E | 1 |
Gennari, C | 1 |
Rubegni, M | 1 |
Forconi, S | 1 |
Romano, S | 1 |
Bell, NH | 1 |
Colwell, JA | 1 |
Saval, F | 1 |
Del Greco, F | 1 |
Casey, DE | 1 |
Calvet, JP | 1 |
Horwith, M | 1 |
Buchanan, JR | 1 |
Gudmundsson, ST | 1 |
Mautalen, CA | 1 |
Judd, DR | 1 |
Heimberger, I | 1 |
Johnston, C | 1 |
Johnston, NG | 1 |
Charvát, J | 1 |
Lindenhayn, K | 1 |
15 reviews available for hydroxyproline and Hyperparathyroidism
Article | Year |
---|---|
URINARY HYDROXYPROLINE EXCRETION AND GROWTH.
Topics: Aging; Blood Chemical Analysis; Chemical Phenomena; Chemistry; Collagen; Diet; Growth; Growth Hormon | 1964 |
[Primary hyperparthyroidism. Analysis of 152 patients with special reference to acute life threatening complications (acute hyperparathyroidism)].
Topics: Acute Disease; Adenoma; Adolescent; Adrenal Glands; Adult; Aged; Alkaline Phosphatase; Body Weight; | 1976 |
[Usefulness of bone remodelling biochemical markers in the diagnosis and follow-up of Paget's bone disease, primary hyperparathyroidism, tumor hypercalcemia, and postmenopausal osteoporosis. II. Bone resorption markers].
Topics: Acid Phosphatase; Adult; Biomarkers; Bone Resorption; Child; Female; Follow-Up Studies; Humans; Hydr | 1990 |
Ionic and hormonal control of calcium homeostasis.
Topics: Animals; Biological Transport; Bone and Bones; Calcitonin; Calcium; Cell Membrane; Cell Membrane Per | 1971 |
[Problems concerning clinical application of calcitonin].
Topics: Adult; Aged; Alkaline Phosphatase; Calcitonin; Calcium; Child, Preschool; Female; Fibrous Dysplasia | 1972 |
[Urinary excretion of hydroxyproline as an index of systemic collagen metabolism].
Topics: Adult; Age Factors; Body Surface Area; Bone and Bones; Bone Diseases; Bone Neoplasms; Calcinosis; Ch | 1972 |
[Diagnosis of primary hyperparathyroidism].
Topics: Acid-Base Equilibrium; Alkaline Phosphatase; Calcium; Humans; Hydroxyproline; Hyperparathyroidism; P | 1974 |
The diagnosis of primary hyperparathyroidism.
Topics: Alkaline Phosphatase; Calcium; Cortisone; Humans; Hydroxyproline; Hypercalcemia; Hyperparathyroidism | 1968 |
[Parathyroid function test].
Topics: Animals; Calcitonin; Calcium; Humans; Hydroxyproline; Hyperparathyroidism; Hypoparathyroidism; Kidne | 1969 |
[Bone changes in hyperparathyroidism].
Topics: Adult; Bone and Bones; Bone Resorption; Calcium; Diagnosis, Differential; Female; Humans; Hydroxypro | 1969 |
Bone disease in intestinal malabsorption.
Topics: Bone and Bones; Bone Diseases; Calcium; Humans; Hydroxyproline; Hyperparathyroidism; Hypoparathyroid | 1970 |
Recent advances in the unerstanding and management of metabolic bone disease.
Topics: Bone Diseases; Calcitonin; Collagen; Homocystinuria; Humans; Hydroxyproline; Hyperparathyroidism; Me | 1970 |
The clinical physiology of calcium homeostasis, parathyroid hormone, and calcitonin. II.
Topics: Adenoma; Alkaline Phosphatase; Calcitonin; Calcium; Dihydrotachysterol; Diuretics; Ergocalciferols; | 1971 |
Recognition of osteodystrophy in chronic uremia.
Topics: Alkaline Phosphatase; Biopsy; Bone and Bones; Bone Diseases; Humans; Hydroxyproline; Hyperparathyroi | 1971 |
Some aspects of metabolic bone disease related to rheumatology.
Topics: Absorptiometry, Photon; Adult; Aged; Aging; Bone Diseases; Bone Resorption; Calcium; Child; Estrogen | 1971 |
4 trials available for hydroxyproline and Hyperparathyroidism
Article | Year |
---|---|
Effects of dichloromethylene diphosphonate on serum and urinary calcium in primary hyperparathyroidism.
Topics: Adult; Aged; Alkaline Phosphatase; Calcium; Clodronic Acid; Cyclic AMP; Diphosphonates; Female; Huma | 1981 |
Effects of infusion of parathyroid hormone and primary hyperparathyroidism on formation and breakdown of type I collagen.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Resorption; Calcium; Collagen; Female; Hu | 1994 |
Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Density; Bone Developmen | 1995 |
Metabolic effects of diphosphonate in primary hyperparathyroidism.
Topics: Adult; Aged; Alkaline Phosphatase; Bone and Bones; Calcium; Clinical Trials as Topic; Cyclic AMP; Di | 1977 |
127 other studies available for hydroxyproline and Hyperparathyroidism
Article | Year |
---|---|
Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: a 2-year study.
Topics: Absorptiometry, Photon; Alendronate; Bone Density; Calcium; Creatinine; Female; Humans; Hydroxyproli | 2002 |
NEONATAL FAMILIAL PRIMARY HYPERPARATHYROIDISM.
Topics: Calcium; Calcium, Dietary; Electrocardiography; Genetics, Medical; Glycine; Humans; Hydroxyproline; | 1964 |
HYDROXYPROLINE EXCRETION IN ENDOCRINE DISEASE.
Topics: Acromegaly; Adolescent; Adrenocorticotropic Hormone; Aldosterone; Anabolic Agents; Cushing Syndrome; | 1963 |
CORRELATION OF URINARY HYDROXYPROLINE, SERUM ALKALINE PHOSPHATASE AND SKELETAL CALCIUM TURNOVER.
Topics: Alkaline Phosphatase; Bone and Bones; Bone Diseases; Bone Neoplasms; Breast Neoplasms; Calcium; Geri | 1964 |
URINARY HYDROXYPROLINE IN DISEASES INVOLVING BONE AND CALCIUM METABOLISM.
Topics: Acute Kidney Injury; Alkaline Phosphatase; Bone Diseases; Bone Neoplasms; Breast Neoplasms; Calcium; | 1964 |
PARATHYROID HORMONE AND URINARY HYDROXYPROLINE.
Topics: Acromegaly; Adenoma; Adolescent; Blood; Calcium; Calcium, Dietary; Geriatrics; Humans; Hydroxyprolin | 1965 |
EXCRETION OF PYROPHOSPHATE IN DISORDERS OF BONE METABOLISM.
Topics: Bone Neoplasms; Bone Resorption; Chromatography; Diphosphates; Fluids and Secretions; Humans; Hydrox | 1965 |
[Urinary hydroxy-proline in patients with urolithiasis].
Topics: Bone Neoplasms; Decalcification, Pathologic; Fractures, Bone; Humans; Hydroxyproline; Hyperparathyro | 1966 |
[A method of fractionating urinary peptides containing hydroxyproline].
Topics: Acromegaly; Arthritis, Rheumatoid; Bone Neoplasms; Chemistry, Clinical; Chromatography, Ion Exchange | 1967 |
Acute effects of calcium infusion on hydroxyproline.
Topics: Calcium; Gluconates; Humans; Hydroxyproline; Hyperparathyroidism; Osteomalacia; Uremia | 1967 |
Total urinary hydroxyproline in primary hyperparathyroidism. An assessment of its clinical significance.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Biopsy; Body Surface Area; Bone Diseases; Female; Hum | 1967 |
Acute effects of removal of parathyroid adenoma on plasma and urinary hydroxyproline levels.
Topics: Adenoma; Cyclic AMP; Humans; Hydroxyproline; Hyperparathyroidism; Parathyroid Neoplasms | 1984 |
Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease.
Topics: Alkaline Phosphatase; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Humans; Hydroxyproli | 1980 |
[Role of laboratory studies in the diagnosis of hyperparathyroid osteodystrophy].
Topics: Acid Phosphatase; Adult; Aged; Alkaline Phosphatase; Calcium; Female; Humans; Hydroxyproline; Hyperp | 1981 |
Conjugated estrogens in the treatment of postmenopausal women with hyperparathyroidism.
Topics: Adult; Aged; Alkaline Phosphatase; Biopsy; Calcitriol; Calcium; Cyclic AMP; Drug Evaluation; Estroge | 1984 |
Bone mass as referent for urinary hydroxyproline excretion: age and sex-related changes in 125 normals and in primary hyperparathyroidism.
Topics: Adult; Age Factors; Aged; Bone and Bones; Bone Resorption; Creatinine; Female; Humans; Hydroxyprolin | 1984 |
Treatment of primary hyperparathyroidism with cyclofenil--a synthetic stilbestrol derivative with minimal feminizing effects.
Topics: Aged; Calcium; Cresols; Cyclofenil; Female; Feminization; Humans; Hydroxyproline; Hyperparathyroidis | 1984 |
The activity of the bone isoenzyme of serum alkaline phosphatase and urinary hydroxyproline excretion in premenopausal and postmenopausal women with primary hyperparathyroidism.
Topics: Adolescent; Adult; Alkaline Phosphatase; Bone and Bones; Calcium; Estrogens; Female; Humans; Hydroxy | 1984 |
[Hydroxyproline in morning urine. A reliable parameter for bone turnover in childhood].
Topics: Adolescent; Adult; Age Factors; Alkaline Phosphatase; Bone and Bones; Child; Child, Preschool; Creat | 1983 |
[Urinary excretion of hydroxyproline in parathyroid disorders, with special reference to its changes before and after parathyroidectomy in primary hyperparathyroidism].
Topics: Adult; Aged; Circadian Rhythm; Female; Humans; Hydroxyproline; Hyperparathyroidism; Male; Middle Age | 1983 |
Calcitonin secretion and bone disease severity in hypercalcaemic hyperparathyroidism.
Topics: Adolescent; Adult; Bone Diseases; Calcitonin; Calcium; Female; Humans; Hydroxyproline; Hypercalcemia | 1981 |
Asymptomatic hyperparathyroidism: an assessment of operative intervention.
Topics: Alkaline Phosphatase; Calcium; Female; Follow-Up Studies; Humans; Hydroxyproline; Hypercalcemia; Hyp | 1980 |
The relation between bone loss and calcium balance in women.
Topics: Aged; Alkaline Phosphatase; Bone and Bones; Bone Regeneration; Bone Resorption; Calcium; Female; Fem | 1980 |
Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism.
Topics: Aged; Alendronate; Biomarkers; Bone Resorption; Diphosphonates; Female; Humans; Hydroxylysine; Hydro | 1994 |
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone.
Topics: Aged; Alendronate; Alkaline Phosphatase; Bone Diseases, Metabolic; Bone Resorption; Calcium; Diphosp | 1994 |
Biochemical effects of a calcium supplement in postmenopausal women with primary hyperparathyroidism.
Topics: Absorption; Aged; Aged, 80 and over; Bone Resorption; Calcium; Creatinine; Female; Humans; Hydroxypr | 1994 |
Serum carboxy-terminal propeptide of human type I procollagen in patients with primary hyperparathyroidism: studies in basal conditions and after parathyroid surgery.
Topics: Adenoma; Adult; Aged; Alkaline Phosphatase; Calcium; Creatinine; Female; Humans; Hydroxyproline; Hyp | 1994 |
Acute changes in calcium homeostasis during treatment of primary hyperparathyroidism with risedronate.
Topics: Administration, Oral; Aged; Alkaline Phosphatase; Analysis of Variance; Bone Resorption; Calcium; Et | 1993 |
Trabecular bone mineral density in primary hyperparathyroidism: relationship to clinical presentation and biomarkers of skeletal turnover.
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Biomarkers; Bone Density; Calcium; Creatinine; Female; | 1993 |
Serum osteocalcin in metabolic bone diseases: what is its real significance?
Topics: Adult; Alkaline Phosphatase; Bone Diseases; Bone Resorption; Calcitonin; Female; Humans; Hydroxyprol | 1993 |
Markers of bone remodeling in the elderly subject: effects of vitamin D insufficiency and its correction.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Amino Acids; Bone Remodeling; Calcium; Female; Humans | 1995 |
The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism.
Topics: Absorptiometry, Photon; Acid Phosphatase; Adenoma; Adult; Aged; Alkaline Phosphatase; Bone Density; | 1997 |
Clinical profile of 128 subjects operated for primary hyperparathyroidism.
Topics: Adenoma; Adolescent; Adult; Aged; Alkaline Phosphatase; Bone Density; Calcitriol; Calcium; Diagnosis | 1998 |
Relationship of the activity of the bone isoenzyme of serum alkaline phosphatase to urinary hydroxyproline excretion in metabolic and neoplastic bone diseases.
Topics: Acromegaly; Adult; Alkaline Phosphatase; Bone Diseases; Bone Neoplasms; Female; Humans; Hydroxyproli | 1978 |
Observations on the mechanism of 99mTc-labeled phosphate complex uptake in metabolic bone disease.
Topics: Aminopropionitrile; Animals; Bone and Bones; Chronic Kidney Disease-Mineral and Bone Disorder; Dipho | 1976 |
[Value and relevance of metabolic function tests in the diagnosis of primary hyperparathyroidism (author's transl)].
Topics: Alkaline Phosphatase; Calcium; Creatinine; Cyclic AMP; Humans; Hydroxyproline; Hyperparathyroidism; | 1976 |
Congenital hyperparathyroidism and vitamin D deficiency secondary to maternal hypoparathyroidism.
Topics: Calcium; Cyclic AMP; Female; Humans; Hydroxycholecalciferols; Hydroxyproline; Hyperparathyroidism; H | 1976 |
Relationship between bone uptake of 99mTc-pyrophosphate and hydroxyproline in blood and urine.
Topics: Aged; Bone and Bones; Bone Diseases; Diphosphates; Female; Humans; Hydroxyproline; Hyperparathyroidi | 1976 |
Urinary excretion of calcium, hydroxyproline and 3',5'-cyclic adenosine monophosphate in primary hyperparathyroidism.
Topics: Adult; Aged; Calcium; Circadian Rhythm; Cyclic AMP; Fasting; Female; Humans; Hydroxyproline; Hyperpa | 1979 |
Hydroxyproline excretion following renal transplantation: comparison with values found in primary hyperparathyroidism.
Topics: Adult; Female; Humans; Hydroxyproline; Hypercalcemia; Hyperparathyroidism; Kidney Failure, Chronic; | 1977 |
[Osteitis deformans (Paget)--or a tarda-type of a hereditary hyperphosphatasia (author's transl)].
Topics: Adult; Alkaline Phosphatase; Bone Transplantation; Calcitonin; Deafness; Diagnosis, Differential; Di | 1979 |
Bone mineralization and bone mineral content in primary hyperparathyroidism.
Topics: Adult; Aged; Bone and Bones; Calcium; Female; Humans; Hydroxyproline; Hyperparathyroidism; Male; Mid | 1977 |
[Plasma hydroxyproline determination in patients with metabolic diseases of the bone collagen].
Topics: Acromegaly; Adult; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hydroxyproline; Hyperpa | 1978 |
Bone, calcium, and hydroxyproline metabolism in hyperparathyroidism and after removal of parathyroid adenoma.
Topics: Adenoma; Aged; Alkaline Phosphatase; Bone and Bones; Bone Resorption; Calcium; Female; Humans; Hydro | 1977 |
Physiological hyperparathyroidism in human lactation.
Topics: Alkaline Phosphatase; Calcium; Female; Humans; Hydroxycholecalciferols; Hydroxyproline; Hyperparathy | 1977 |
Urinary hydroxyproline concentration in primary hyperparathyroidism with and without renal stones.
Topics: Adult; Alkaline Phosphatase; Calcium; Creatinine; Female; Humans; Hydroxyproline; Hyperparathyroidis | 1977 |
Relation to osteoporosis of age- and hormone-induced changes in the metabolism of collagen and bone.
Topics: Aging; Animals; Bone and Bones; Bone Matrix; Calcium; Collagen; Female; Hormones; Humans; Hydroxypro | 1976 |
Comparative response to parathyroid hormone in hyperthyroidism and hypothyroidism.
Topics: Adult; Aged; Alkaline Phosphatase; Antigens; Bone and Bones; Calcium; Female; Humans; Hydroxyproline | 1975 |
Primary hyperparathyroidism. Laboratory and clinical data in 73 cases.
Topics: Adenoma; Adolescent; Adult; Age Factors; Aged; Bone Diseases; Calcium; Depression; Female; Glomerula | 1975 |
[Chromatographic analysis of urinary amino acids in Paget's disease. II : clinical study].
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Amino Acids; Bone Diseases; Bone Neoplasms; Calcitoni | 1976 |
Effects of ipriflavone on bone remodeling in primary hyperparathyroidism.
Topics: Adult; Aged; Bone Remodeling; Calcium; Creatinine; Female; Humans; Hydroxyproline; Hyperparathyroidi | 1992 |
Borderline-low serum thyrotropin level is correlated with increased fasting urinary hydroxyproline excretion.
Topics: Aged; Bone Diseases, Metabolic; Calcium; Creatinine; Fasting; Female; Humans; Hydroxyproline; Hyperp | 1992 |
[Effect of secondary hyperparathyroidism upon serum hydroxyproline in patients with renal failure].
Topics: Adult; Female; Humans; Hydroxyproline; Hyperparathyroidism; Kidney Failure, Chronic; Male; Middle Ag | 1991 |
Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases.
Topics: Aged; Aged, 80 and over; Amino Acids; Biomarkers; Bone Diseases, Metabolic; Bone Resorption; Collage | 1991 |
[Clinico-biochemical parallels in diverse forms of primary hyperparathyroidism].
Topics: Acid Phosphatase; Adenoma; Alkaline Phosphatase; Calcium; Humans; Hydroxyproline; Hyperparathyroidis | 1989 |
Clinical value of the measurement of bone remodelling markers in primary hyperparathyroidism.
Topics: Adult; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Density; Female; Humans; Hydroxyprolin | 1989 |
[Significance of hydroxyproline analysis in clinical tests].
Topics: Adolescent; Adult; Aged; Gelatin; Humans; Hydroxyproline; Hyperparathyroidism; Hyperthyroidism; Marf | 1989 |
Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism.
Topics: Adult; Alkaline Phosphatase; Biomarkers; Biomarkers, Tumor; Bone and Bones; Bone Neoplasms; Breast N | 1989 |
Osteocalcin and bone remodelling in Paget's disease of bone, primary hyperparathyroidism, hypercalcaemia of malignancy and involutional osteoporosis.
Topics: Aged; Alkaline Phosphatase; Calcium-Binding Proteins; Creatinine; Female; Humans; Hydroxyproline; Hy | 1989 |
Clodronate in the medical management of hyperparathyroidism.
Topics: Administration, Oral; Bone Resorption; Clodronic Acid; Diphosphonates; Humans; Hydroxyproline; Hyper | 1987 |
Serum osteocalcin levels and bone alkaline phosphatase isoenzyme after oophorectomy and in primary hyperparathyroidism.
Topics: Acid Phosphatase; Adult; Aged; Alkaline Phosphatase; Bone and Bones; Calcium-Binding Proteins; Cycli | 1987 |
Serum osteocalcin in primary hyperparathyroidism: short-term effect of surgery.
Topics: 1-Carboxyglutamic Acid; Alkaline Phosphatase; Calcium-Binding Proteins; Creatinine; Female; Humans; | 1988 |
Primary hyperparathyroidism and hyperuricaemia are associated but not correlated with indicators of bone turnover.
Topics: Adult; Aged; Alkaline Phosphatase; Bone and Bones; Bone Regeneration; Female; Gout; Humans; Hydroxyp | 1987 |
Osteocalcin and urinary hydroxyproline/creatinine ratio in the differential diagnosis of primary hyperparathyroidism and hypercalcaemia of malignancy.
Topics: Adult; Aged; Alkaline Phosphatase; Calcium-Binding Proteins; Creatinine; Diagnosis, Differential; Fe | 1987 |
Correlation between mass of parathyroid adenoma and biochemical indicators of bone turnover in patients with primary hyperparathyroidism.
Topics: Adenoma; Adult; Aged; Alkaline Phosphatase; Bone and Bones; Female; Humans; Hydroxyproline; Hyperpar | 1986 |
Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women.
Topics: Bone Resorption; Calcitriol; Calcium; Ethinyl Estradiol; Female; Humans; Hydroxyproline; Hyperparath | 1986 |
Treatment of postmenopausal hyperparathyroidism with norethindrone. Effects on biochemistry and forearm mineral density.
Topics: Aged; Bone and Bones; Calcium; Creatinine; Female; Humans; Hydroxyproline; Hyperparathyroidism; Meno | 1987 |
Parathyroid function and vitamin D status in patients with bone metastases of prostatic origin.
Topics: Aged; Alkaline Phosphatase; Bone Neoplasms; Calcifediol; Calcitriol; Calcium; Humans; Hydroxyproline | 1985 |
Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion.
Topics: Adult; Aged; Alkaline Phosphatase; Bone and Bones; Bone Resorption; Calcification, Physiologic; Calc | 1985 |
Bone mass as referent for urinary hydroxyproline excretion.
Topics: Bone Resorption; Humans; Hydroxyproline; Hyperparathyroidism; Reference Values | 1985 |
Clinical significance of free plasma hydroxyproline measurement in metabolic bone disease.
Topics: Adult; Aged; Amino Acids; Bone Diseases, Metabolic; Female; Humans; Hydroxyproline; Hyperparathyroid | 1985 |
Treatment with with oestrogens of primary hyperparathyroidism in post-menopausal women.
Topics: Bone Resorption; Calcium; Ethinyl Estradiol; Female; Humans; Hydroxyproline; Hyperparathyroidism; Ki | 1972 |
[Proceedings: Significance of hydroxyproline determination in 24-hour urine].
Topics: Acromegaly; Age Factors; Collagen; Humans; Hydroxyproline; Hyperparathyroidism; Hyperthyroidism; Met | 1974 |
[Differential diagnosis of congenital systemic diseases of the skeleton based on biochemical changes in the body fluids].
Topics: Bone Diseases; Calcium; Cystic Fibrosis; Diagnosis, Differential; Glycosaminoglycans; Humans; Hydrox | 1968 |
[Some endocrinological variations of calcium and phosphorus metabolism].
Topics: Alkaline Phosphatase; Calcitonin; Calcium; Edetic Acid; Humans; Hydroxyproline; Hypercalcemia; Hyper | 1973 |
Hydroxyproline and collagen metabolism. Clinical implications.
Topics: Adolescent; Adult; Aged; Aging; Blood Proteins; Child; Child, Preschool; Collagen; Female; Gelatin; | 1965 |
The urinary excretion of inorganic pyrophosphate in hyperparathyroidism, hyperthyroidism, Paget's disease and other disorders of bone metabolism.
Topics: Adolescent; Adult; Aged; Bone Diseases; Child; Child, Preschool; Diphosphates; Female; Humans; Hydro | 1969 |
Urinary polypeptides related to collagen synthesis.
Topics: Adenoma; Adolescent; Adult; Aged; Amino Acids; Bone Diseases; Carbon Isotopes; Chromatography, Gel; | 1970 |
[Hyperparathyroidism and renal lithiasis. Biological diagnosis. Current exploration methods].
Topics: Aluminum; Calcium; Citrates; Edetic Acid; Humans; Hydroxyproline; Hyperparathyroidism; Kidney Calcul | 1970 |
Laboratory aids in the diagnosis of metabolic bone disease.
Topics: Alkaline Phosphatase; Biopsy; Bone and Bones; Bone Diseases; Calcium; Calcium, Dietary; Cyclic AMP; | 1972 |
Bone as a target organ: toward a better definition of osteoporosis.
Topics: Bone and Bones; Bone Matrix; Bone Resorption; Calcitonin; Calcium; Collagen; Cyclic AMP; Endocrine S | 1973 |
Vitamin D deficiency, spontaneous fractures, and osteopenia in rheumatoid arthritis.
Topics: Aged; Alkaline Phosphatase; Arthritis, Rheumatoid; Bone Diseases; Calcium; Diet; Female; Fractures, | 1974 |
[Normocalcemic fibrocystic osteitis. Apropos of an observation. Diagnostic problem and pathogenic interest].
Topics: Adenoma; Adult; Alkaline Phosphatase; Biopsy; Bone Cysts; Calcium; Diagnosis, Differential; Female; | 1973 |
The effect of ethinyloestradiol on calcium and phosphorus metabolism of post-menopausal women with primary hyperparathyroidism.
Topics: Aged; Alkaline Phosphatase; Blood Proteins; Bone Resorption; Calcium; Calcium Radioisotopes; Creatin | 1973 |
[Collagen in endocrine diseases with bone involvement].
Topics: Acromegaly; Bone and Bones; Bone Diseases; Collagen; Collagen Diseases; Dwarfism, Pituitary; Endocri | 1973 |
UCLA conference: Current concepts of bone metabolism.
Topics: Animals; Bone and Bones; Bone Development; Bone Resorption; Calcitonin; Calcium; Calcium, Dietary; C | 1974 |
Hyperparathyroidism in an elderly adult with hypophosphatasia.
Topics: Adenoma; Aged; Alkaline Phosphatase; Calcium; Female; Femoral Fractures; Humans; Hydroxyproline; Hyp | 1974 |
Regulation of hydroxyproline excretion in hyperparathyroidism.
Topics: Adult; Calcium; Edetic Acid; Humans; Hydroxyproline; Hyperparathyroidism; Middle Aged; Parathyroid H | 1966 |
Nondialyzable urinary hydroxyproline as an index of bone collagen formation.
Topics: Acromegaly; Adolescent; Adult; Aged; Alkaline Phosphatase; Bone and Bones; Bone Resorption; Calciton | 1970 |
A simple and reliable test for the diagnosis of hyperparathyroidism.
Topics: Adolescent; Adult; Calcitonin; Calcium; Female; Humans; Hydroxyproline; Hyperparathyroidism; Hypopar | 1972 |
[Hydroxyprolinuria in skeletal diseases: its correlation with other parameters of bone metabolism].
Topics: Alkaline Phosphatase; Bone and Bones; Bone Diseases; Bone Neoplasms; Calcium; Humans; Hydroxyproline | 1972 |
Primary hyperparathyroidism and proximal renal tubular acidosis: report of two cases.
Topics: Acidosis, Renal Tubular; Adult; Alkaline Phosphatase; Bicarbonates; Calcium; Citrates; Creatinine; F | 1972 |
Osteoporosis in aging rats induced by high phosphorus diets.
Topics: Aging; Animal Nutritional Physiological Phenomena; Animals; Body Weight; Bone and Bones; Bone Resorp | 1972 |
The solubility and synthetic rate of bone collagen in idiopathic osteoporosis.
Topics: Adolescent; Adult; Aging; Bone and Bones; Bone Matrix; Carbon Isotopes; Climacteric; Collagen; DNA; | 1972 |
Plasma kinetics and acute effects of pharmacologic doses of porcine calcitonin in man.
Topics: Adult; Aged; Animals; Calcitonin; Calcium; Chromatography, Ion Exchange; Circadian Rhythm; Computers | 1971 |
New therapies in Paget's disease of bone.
Topics: Administration, Oral; Anti-Bacterial Agents; Bone Resorption; Calcitonin; Calcium; Humans; Hydroxypr | 1971 |
Quantitative histology of bone in hyperparathyroidism. Its relation to clinical features, x-ray, and biochemistry.
Topics: Adult; Aged; Alkaline Phosphatase; Biopsy; Bone and Bones; Bone Resorption; Calcium; Child; Female; | 1971 |
[Study of urinary hydroxyproline in osteopathies].
Topics: Acromegaly; Adult; Aged; Bone Neoplasms; Female; Humans; Hydroxyproline; Hyperparathyroidism; Hypert | 1966 |
Distortions of bone cell metabolism in uremia and their cause.
Topics: Acidosis; Adult; Aged; Animals; Bone Diseases; Bone Resorption; Calcium; Calcium Isotopes; Female; G | 1969 |
[Urinary hydroxyproline and the metabolism of collagen].
Topics: Acromegaly; Bone Diseases; Child; Collagen; Collagen Diseases; Dwarfism, Pituitary; Humans; Hydroxyp | 1969 |
A detailed study of the urinary peptides in a patient with osteomalacia and hyperparathyroidism.
Topics: Adult; Amino Acids; Chromatography, Paper; Collagen; Dipeptides; Electrophoresis; Female; Humans; Hy | 1970 |
Parathyroidectomy in the treatment of renal osteodystrophy. Calcium dynamic studies.
Topics: Adolescent; Adult; Aged; Bone Diseases; Bone Resorption; Calcium; Calcium Isotopes; Female; Humans; | 1970 |
Renal effects of calcitonin.
Topics: Aged; Animals; Bone Resorption; Breast Neoplasms; Calcitonin; Calcium; Female; Humans; Hydroxyprolin | 1970 |
[Clinical, biochemical and roentgenologic changes in hyperparathyroidism from the viewpoint of the orthopedist].
Topics: Adolescent; Alkaline Phosphatase; Bone Diseases; Calcium; Cleidocranial Dysplasia; Diagnosis, Differ | 1970 |
[A study of urinary hydroxyproline in patients with urolithiasis].
Topics: Adolescent; Adult; Aged; Calcium; Child; Colorimetry; Diet; Female; Humans; Hydroxyproline; Hyperpar | 1970 |
Total urinary hydroxyproline in osteomalacia and the effect upon it of treatment with vitamin D.
Topics: Acidosis, Renal Tubular; Adult; Aged; Alkaline Phosphatase; Bicarbonates; Bone and Bones; Calcium; F | 1968 |
Urinary free and total hydroxyproline in hyperparathyroidism and the effect of removal of parathyroid adenoma.
Topics: Adult; Aged; Alkaline Phosphatase; Bone and Bones; Female; Humans; Hydroxyproline; Hyperparathyroidi | 1968 |
A rapid serum screening test for increased osteoblastic activity.
Topics: Adolescent; Adult; Alkaline Phosphatase; Blood Chemical Analysis; Bone and Bones; Bone Development; | 1968 |
The calcium-infusion-hydroxyproline test.
Topics: Adenoma; Adolescent; Adult; Calcium; Female; Humans; Hydroxyproline; Hyperparathyroidism; Male; Midd | 1968 |
[Normocalcemic hyperparathyroidism in malabsorption].
Topics: Calcium; Humans; Hydroxyproline; Hyperparathyroidism; Hypocalcemia; Intestinal Absorption; Malabsorp | 1968 |
[Modern examination methods in secondary hyperparathyroidism].
Topics: Calcium; Calcium Isotopes; Humans; Hydroxyproline; Hyperparathyroidism; Methods; Skull; Strontium Is | 1968 |
[Regression of renal ostitis fibrosa through permanent dialysis].
Topics: Adult; Calcium; Calcium Isotopes; Calcium Metabolism Disorders; Female; Humans; Hydroxyproline; Hype | 1968 |
[Urinary hydroxyproline excretion in primary hyperparathyroidism. A comparison with other diagnostic methods].
Topics: Adenoma; Adult; Aged; Alkaline Phosphatase; Calcium; Creatinine; Diagnosis, Differential; Female; Hu | 1968 |
[Congenital hyperparathyroidism].
Topics: Chromatography, Paper; Humans; Hydroxyproline; Hypercalcemia; Hyperparathyroidism; Hyperplasia; Infa | 1968 |
Correlations between biochemical, kinetic(45Ca) and histological measurements in hyperparathyroidism.
Topics: Alkaline Phosphatase; Bone and Bones; Bone Resorption; Calcium; Calcium Isotopes; Humans; Hydroxypro | 1969 |
Normocalcemic secondary hyperparathyroidism and malabsorption.
Topics: Adult; Bone and Bones; Calcium; Celiac Disease; Glomerular Filtration Rate; Humans; Hydroxyproline; | 1969 |
Urinary hydroxyproline excretion in coalworkers' pneumoconiosis.
Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Coal Mining; Collagen; Female; Humans; Hydroxyprolin | 1969 |
Metabolic studies of human bone in vitro. II. Changes in hyperparathyroidism.
Topics: Adult; Aged; Alkaline Phosphatase; Animals; Bone and Bones; Collagen; Female; Glucose; Humans; Hydro | 1965 |
Plasma hydroxyproline and proline in primary hyperparathyroidism and in chronic uremia.
Topics: Blood Chemical Analysis; Chemistry, Clinical; Humans; Hydroxyproline; Hyperparathyroidism; Proline; | 1965 |
[Correlation between hydroxyprolinuria, alkaline phosphatasemia and Ca45 dynamics].
Topics: Adult; Aged; Alkaline Phosphatase; Bone Resorption; Calcium; Female; Humans; Hydroxyproline; Hyperpa | 1965 |
Effects of calcium infusion on urinary hydroxyproline and phosphorus: evaluation as a diagnostic test.
Topics: Acromegaly; Adolescent; Adult; Aged; Calcium; Child; Female; Humans; Hydroxyproline; Hypercalcemia; | 1966 |
[Biological diagnosis--postoperative outcome in 25 cases of primary hyperparathyroidism].
Topics: Alkaline Phosphatase; Calcium Metabolism Disorders; Citrates; Humans; Hydroxyproline; Hyperparathyro | 1966 |
Primary hyperparathyroidism--evaluation of diagnostic aids: calcium infusion, phosphorus deprivation and hydroxyprolinuria.
Topics: Calcium; Diet; Humans; Hydroxyproline; Hyperparathyroidism; Kidney Calculi; Osteoporosis; Phosphates | 1966 |
Parathyroid adenoma.
Topics: Adenoma; Adolescent; Adult; Aged; Alkaline Phosphatase; Calcium; Female; Humans; Hydroxyproline; Hyp | 1966 |
Urinary hydroxyproline and the bone in primary and secondary hyperparathyroidism.
Topics: Adenoma; Adolescent; Adult; Bone and Bones; Female; Humans; Hydroxyproline; Hyperparathyroidism; Kid | 1966 |
[Diagnosis of primary hyperparathyroidism].
Topics: Diagnosis, Differential; Humans; Hydroxyproline; Hyperparathyroidism; Osteomalacia; Osteoporosis; Pr | 1966 |
[On the excretion of bound hydroxyproline as an expression of changes in the organic cartilage and bone matrix].
Topics: Adolescent; Bone and Bones; Bone Diseases; Bone Neoplasms; Breast Neoplasms; Cartilage; Ehlers-Danlo | 1966 |